4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Care in Diabetes—2023
NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2022 - pmc.ncbi.nlm.nih.gov
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Primary Care Guidance for Providers Who Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious …
M Horberg, M Thompson, A Agwu… - Clinical Infectious …, 2024 - academic.oup.com
Advances in antiretroviral therapy (ART) have made it possible for persons with human
immunodeficiency virus (HIV) to live a lifespan approaching that of people without HIV …
immunodeficiency virus (HIV) to live a lifespan approaching that of people without HIV …
[HTML][HTML] Use of 21-valent pneumococcal conjugate vaccine among US adults: recommendations of the Advisory Committee on Immunization Practices—United States …
M Kobayashi - MMWR. Morbidity and mortality weekly report, 2024 - cdc.gov
Abstract On June 17, 2024, the Food and Drug Administration approved 21-valent
pneumococcal conjugate vaccine (PCV)(PCV21; CAPVAXIVE; Merck Sharp & Dohme, LLC) …
pneumococcal conjugate vaccine (PCV)(PCV21; CAPVAXIVE; Merck Sharp & Dohme, LLC) …
Prevalence, clinical severity, and serotype distribution of pneumococcal pneumonia among adults hospitalized with community-acquired pneumonia in Tennessee …
WH Self, KD Johnson, JJ Resser… - Clinical Infectious …, 2024 - academic.oup.com
Introduction Understanding the pneumococcal serotypes causing community-acquired
pneumonia (CAP) is essential for evaluating the impact of pneumococcal vaccines. Methods …
pneumonia (CAP) is essential for evaluating the impact of pneumococcal vaccines. Methods …
[HTML][HTML] Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged≥ 50 years: recommendations of the Advisory Committee on …
M Kobayashi - MMWR. Morbidity and Mortality Weekly Report, 2025 - cdc.gov
Abstract Before October 2024, the Advisory Committee on Immunization Practices (ACIP)
recommended use of a pneumococcal conjugate vaccine (PCV) for all adults aged≥ 65 …
recommended use of a pneumococcal conjugate vaccine (PCV) for all adults aged≥ 65 …
[HTML][HTML] Health care provider knowledge and attitudes regarding adult pneumococcal conjugate vaccine recommendations—United States, September 28–October 10 …
R Kahn - MMWR. Morbidity and mortality weekly report, 2023 - cdc.gov
Despite the availability of effective vaccines against pneumococcal disease, pneumococcus
is a common bacterial cause of pneumonia, causing approximately 100,000 hospitalizations …
is a common bacterial cause of pneumonia, causing approximately 100,000 hospitalizations …
Invasive Pneumococcal Disease and Potential Impact of Pneumococcal Conjugate Vaccines Among Adults, Including Persons Experiencing Homelessness—Alaska …
J Steinberg, SS Bressler, L Orell… - Clinical Infectious …, 2024 - academic.oup.com
Background Adults aged≥ 65 years, adults with certain underlying medical conditions, and
persons experiencing homelessness are at increased risk for invasive pneumococcal …
persons experiencing homelessness are at increased risk for invasive pneumococcal …
Recommended adult immunization schedule, United States, 2024
N Murthy, AP Wodi, VV McNally, MF Daley… - Annals of Internal …, 2024 - acpjournals.org
This article provides immunization recommendations from the Advisory Committee on
Immunization Practices (ACIP) for adults aged 19 years or older. The purpose of the …
Immunization Practices (ACIP) for adults aged 19 years or older. The purpose of the …
Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates cultured from Japanese adult patients with community-acquired …
T Miyazaki, M Van Der Linden, K Hirano… - Frontiers in …, 2024 - frontiersin.org
Streptococcus pneumoniae is an important cause of community-acquired pneumonia (CAP)
in Japan. Here, we report the serotype distribution and antimicrobial susceptibility of cultured …
in Japan. Here, we report the serotype distribution and antimicrobial susceptibility of cultured …
The present and future of the adult pneumococcal vaccine program in the United States
M Kobayashi, AL Cohen, KA Poehling - NEJM evidence, 2023 - evidence.nejm.org
Streptococcus pneumoniae (pneumococcus) is a common cause of bacterial respiratory
infections, such as pneumonia, sinusitis, and acute otitis media, and it also causes invasive …
infections, such as pneumonia, sinusitis, and acute otitis media, and it also causes invasive …